GlassScriptPhysician profile
Nasir A Asghar
NPI 1235394768
$18,073.33
in general payments reported to CMS, 2019-2025
52 companies · $2,643 in 2025
The $2,643 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,759 · 2020: $2,486 · 2021: $4,106 · 2022: $2,455 · 2023: $2,311 · 2024: $2,313 · 2025: $2,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,254 · Entertainment: $13.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,253.78 |
| Entertainment | $13.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,740.01 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $2,232.20 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $1,322.00 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $1,283.89 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Sanofi-Aventis U.S. LLC | $1,148.82 | 2019-2025 | |
| Axsome Therapeutics, INC. | $869.45 | 2022-2025 | Auvelity, Symbravo |
| Takeda Pharmaceuticals U.S.A., INC. | $781.90 | 2020-2025 | Trintellix, Glassia |
| Glaxosmithkline, LLC. | $749.86 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $733.79 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $712.30 | 2019-2025 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $428.70 | 2019-2025 | Xifaxan |
| Antares Pharma, INC. | $414.33 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Lundbeck LLC | $360.76 | 2020-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $355.47 | 2019-2025 | Jardiance |
| Allergan, INC. | $347.43 | 2019-2021 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $331.72 | 2019-2024 | Repatha, Otezla |
| Otsuka America Pharmaceutical, INC. | $329.13 | 2019-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $316.04 | 2022-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $234.81 | 2021-2023 | |
| Corcept Therapeutics | $228.51 | 2021-2025 | Korlym |
| Merck Sharp & Dohme LLC | $225.24 | 2019-2025 | Belsomra, Steglatro, Capvaxive |
| Supernus Pharmaceuticals, INC. | $194.25 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $147.69 | 2019-2022 | |
| Abbott Laboratories | $147.14 | 2021-2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $121.38 | 2020-2025 | Zoryve |
| Idorsia Pharmaceuticals US INC | $114.80 | 2022-2025 | Quviviq, Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $106.66 | 2022 | |
| Esperion Therapeutics, INC. | $105.61 | 2020-2024 | Nexletol |
| Daiichi Sankyo INC. | $105.55 | 2022-2023 | Injectafer |
| Biohaven Pharmaceuticals, INC. | $101.95 | 2021 | |
| Exact Sciences Corporation | $100.05 | 2023-2024 | Cologuard Collection Kit |
| Genentech USA, INC. | $77.53 | 2020-2021 | |
| Eisai INC. | $72.12 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $68.65 | 2019-2023 | |
| Medtronic, INC. | $51.63 | 2022-2023 | Venaseal |
| Arbor Pharmaceuticals, INC. | $51.12 | 2021-2022 | |
| Amarin Pharma, INC. | $48.03 | 2020-2021 | |
| Astellas Pharma US INC | $40.19 | 2025 | Veozah |
| Mylan Specialty L.P. | $31.50 | 2020-2021 | |
| Currax Pharmaceuticals LLC | $29.47 | 2023-2024 | Contrave, Onzetra Xsail |
| Vanda Pharmaceuticals INC. | $29.35 | 2025 | Fanapt |
| Inspire Medical Systems, INC. | $22.45 | 2025 | Inspire |
| Upsher-Smith Laboratories LLC | $21.44 | 2022 | |
| Paratek Pharmaceuticals, INC. | $19.94 | 2024 | Nuzyra |
| Ascensia Diabetes Care US INC. | $19.62 | 2024 | |
| Tolmar, INC. | $17.12 | 2023 | |
| Xeris Pharmaceuticals, INC. | $16.52 | 2024 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $15.30 | 2021 | |
| Baxter Healthcare | $13.58 | 2022 | |
| Optos, INC. | $13.15 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Avion Pharmaceuticals | $11.80 | 2020 | |
| Medicure Pharma INC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nasir Asghar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.